India readies five sites for final phase of human trials of Oxford COVID vaccine
Published
New Delhi: Five sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine, Department of Biotechnology (DBT) Secretary Renu Swarup said on Monday.
This is an essential step because it is necessary to have data within the country before the vaccine is...